Tiragolumab Fails in Extensive-Stage Small Cell Lung Cancer
(MedPage Today) -- CHICAGO -- Combining the novel human anti-TIGIT monoclonal antibody tiragolumab with atezolizumab (Tecentriq) plus chemotherapy failed to improve outcomes in patients with untreated extensive-stage small cell lung cancer (SCLC...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Hematology | Lung Cancer | Small Cell Lung Cancer